FirstString Research, Inc. v. JSS Medical Research Inc.

CourtCourt of Chancery of Delaware
DecidedMay 28, 2021
DocketC.A. No. 2020-0332-KSJM
StatusPublished

This text of FirstString Research, Inc. v. JSS Medical Research Inc. (FirstString Research, Inc. v. JSS Medical Research Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
FirstString Research, Inc. v. JSS Medical Research Inc., (Del. Ct. App. 2021).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

FIRSTSTRING RESEARCH, INC., ) ) Plaintiff, ) v. ) C.A. No. 2020-0332-KSJM ) JSS MEDICAL RESEARCH INC., ) ) Defendant. )

MEMORANDUM OPINION

Date Submitted: February 15, 2021 Date Decided: May 28, 2021

Myron T. Steele, John A. Sensing, Jesse L. Noa, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Cory E. Manning, NELSON MULLINS RILEY & SCARBOROUGH LLP, Columbia, South Carolina; Carrie A. Hanger, NELSON MULLINS RILEY & SCARBOROUGH LLP, Winston-Salem, North Carolina, Wesley T. Moran, NELSON MULLINS RILEY & SCARBOROUGH LLP, Myrtle Beach, South Carolina; Counsel for Plaintiff FirstString Research, Inc.

Steven L. Caponi, Matthew B. Goeller, K&L GATES LLP, Wilmington, Delaware; Counsel for Defendant JSS Medical Research Inc.

McCORMICK, C. The defendant entered into an agreement to manage clinical studies for an

investigational new drug developed by the plaintiff. One of the studies was delayed and

ultimately terminated. The plaintiff filed this action for breach of contract alleging that the

defendant mismanaged the study in ways that contributed to its overall failure. In addition

to damages, the plaintiff seeks specific performance of the defendant’s obligation to

cooperate in winding down the study. After the plaintiffs filed this action, the defendant

filed mirror-image breach of contract claims against the plaintiff in the Superior Court of

the State of Delaware. In the Superior Court action, the defendant demanded a jury trial.

The defendant has moved to transfer this action to the Superior Court, arguing that the

plaintiff’s request for specific performance is pretextual and insufficient to vest this court

with subject matter jurisdiction. The defendant further argues that it has a constitutional

right to a jury trial on its mirror-image claims such that a transfer of this action is necessary.

This decision holds that the complaint, objectively viewed, discloses a genuine need

for equitable relief and that this court has jurisdiction over the entire action under the

equitable clean-up doctrine. Further, because this court has jurisdiction to hear and decide

the entirety of the plaintiff’s complaint, the defendant does not have a right to a jury trial

on its counterclaims. The defendant’s motion to transfer is denied.

I. FACTUAL BACKGROUND

The facts are drawn from the Verified Complaint (the “Complaint”) 1 and documents

it incorporates by reference.

1 C.A. No. 2020-0332-KSJM, Docket (“Dkt.”) 1, Verified Compl., Filed on Behalf of Pl. FirstString Research, Inc. (“Compl.”). A. The Agreement

FirstString Research, Inc. (“FirstString” or “Plaintiff”) is a biopharmaceutical

company that “specializes in developing treatments for diseases associated with

dysregulation of inflammatory processes and modulation of injury response.” 2 FirstString

developed a drug called “Granexin Gel (ACT1 Peptide)” (“Granexin”), which received

investigational new drug approval from the United States Food and Drug Administration. 3

JSS Medical Research Inc. (“JSS” or “Defendant”) is a contract research

organization that conducts clinical research studies. 4

By a Master Services Agreement dated February 19, 2018 (the “Agreement”), 5

FirstString retained JSS as a general contractor to “provide clinical research, data

management and project management” for various clinical research studies. 6

The Agreement stated that “[a]ll data developed relating to a study” is “the sole and

exclusive property of [FirstString].” 7 In the event of termination, the parties agreed that

“JSS shall transfer to [FirstString] all Developments including any and all copies and/or

derivatives hereof, made by JSS . . . as well as any writings, drawings, specifications,

manuals or other printed material made by JSS . . . to the extent . . . not already transferred

2 Id. ¶¶ 1, 6. 3 Id. ¶ 7. 4 Id. ¶¶ 2, 11. 5 Compl. Ex. A (“Agreement”). 6 Id. ¶ 2; Compl. ¶ 13. 7 Agreement ¶ 17.7.

2 prior to expiration or termination.” 8 The parties further agreed “that termination of this

[Agreement] and/or any Work Order in progress will require discussion and co-ordination

to ensure subject safety, continuity/discontinuity of treatment, and compliance with local

and/or national regulations.” 9

B. The Work Order

The Agreement contemplated that JSS would perform numerous clinical studies and

that the parties would execute a work order outlining specific project requirements and

terms of compensation for each individual study.

On February 20, 2018, FirstString and JSS executed a work order (the “Work

Order”) 10 governing a “GAIT Study,” which “focused on the safety and efficacy of

Granexin for the treatment of diabetic foot ulcers.” 11

The Work Order incorporated the Agreement by reference, noting that “the

[Agreement] and this Work Order with its Schedules shall be read, taken and construed as

one and the same agreement.” 12 It provided details of the GAIT Study’s objectives and

design, including the number and types of patients, the types of treatments, the desired

endpoints, and the methods of statistical analysis to be used. It included a total study budget

8 Id. ¶ 17.6. 9 Id. ¶ 12.6. 10 Compl. Ex. B (“Work Order”). 11 Compl. ¶ 12. 12 Work Order ¶ 5.

3 of almost $6.5 million, a 35-month study timeline, and a payment plan entitling JSS to

milestone payments during the study.

C. The Amendment

Two problems arose early in the GAIT Study. The first problem was a delay due in

part to insufficient patient recruitment. Plaintiff alleges that JSS contributed to the delay

by providing insufficient site monitoring and generally mismanaging the project.

The second problem involved nonpayment to third parties. Pursuant to the

Agreement and Work Order, FirstString had transferred funds to JSS throughout the GAIT

Study to pay third-party clinical sites for their services. FirstString, however, began to

receive complaints from those clinical sites indicating that “JSS had failed to pay their

invoices in a timely manner.” 13

In an effort to put the GAIT Study back on course and address nonpayment issues,

the parties amended the Agreement and Work Order on April 9, 2019 (the

“Amendment”). 14

The Amendment removed FirstString’s obligation to pay JSS for “all amounts owed

for the Services performed by it” in the event the Agreement or any Work Order “is

terminated for any reason.” 15 It further added $500,000 in “additional start-up funds” to

13 Compl. ¶ 24. 14 Compl. Ex. D (“Amendment”). 15 Id. ¶ 1.

4 the GAIT Study’s budget, payable upon execution of the Amendment. 16 Lastly, it

obligated JSS to pay third-party vendors in a timely manner and gave FirstString the right

to “terminate and transfer” the GAIT Study to another contract research organization if JSS

missed certain milestones specified in the Amendment. 17

D. The Termination

The Amendment did not put the GAIT Study back on course. According to Plaintiff,

JSS continued to miss deadlines and FirstString continued to receive complaints of

nonpayment by JSS from the GAIT Study’s third-party clinical sites. Shortly after

FirstString closed patient enrollment in February 2020, FirstString asked JSS for a revised

budget proposal detailing the cost of “all study termination and close out activities.” 18 The

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Walker v. Sauvinet
92 U.S. 90 (Supreme Court, 1876)
Beacon Theatres, Inc. v. Westover
359 U.S. 500 (Supreme Court, 1959)
Candlewood Timber Group, LLC v. Pan American Energy, LLC
859 A.2d 989 (Supreme Court of Delaware, 2004)
Claudio v. State
585 A.2d 1278 (Supreme Court of Delaware, 1991)
Getty Refining & Marketing Co. v. Park Oil, Inc.
385 A.2d 147 (Court of Chancery of Delaware, 1978)
Graham v. State Farm Mutual Automobile Insurance
565 A.2d 908 (Supreme Court of Delaware, 1989)
Park Oil, Inc. v. Getty Refining & Marketing Co.
407 A.2d 533 (Supreme Court of Delaware, 1979)
Clark v. Teeven Holding Co., Inc.
625 A.2d 869 (Court of Chancery of Delaware, 1992)
International Business MacHines Corp. v. Comdisco, Inc.
602 A.2d 74 (Court of Chancery of Delaware, 1991)
In Re Markel
254 A.2d 236 (Supreme Court of Delaware, 1969)
Saunders v. Saunders
71 A.2d 258 (Supreme Court of Delaware, 1950)
Wilmont Homes, Inc. v. Weiler
202 A.2d 576 (Supreme Court of Delaware, 1964)
McMahon v. New Castle Associates
532 A.2d 601 (Court of Chancery of Delaware, 1987)
McCool v. Gehret
657 A.2d 269 (Supreme Court of Delaware, 1995)
Waters v. Comly
3 Del. 117 (Supreme Court of Delaware, 1840)
Organovo Holdings, Inc. v. Dimitrov
162 A.3d 102 (Court of Chancery of Delaware, 2017)
Strickler v. Sussex Life Care Associates
541 A.2d 587 (Superior Court of Delaware, 1987)
Sparks v. President of the Farmers' Bank
3 Del. Ch. 225 (Court of Chancery of Delaware, 1868)
Mackenzie Oil Co. v. Omar Oil & Gas Co.
120 A. 852 (Court of Chancery of Delaware, 1923)
Glanding v. Industrial Trust Co.
45 A.2d 553 (Supreme Court of Delaware, 1945)

Cite This Page — Counsel Stack

Bluebook (online)
FirstString Research, Inc. v. JSS Medical Research Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/firststring-research-inc-v-jss-medical-research-inc-delch-2021.